We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cell-line Derived Controls for Diagnostic Assay Development

Product News   Sep 29, 2017

 
Cell-line Derived Controls for Diagnostic Assay Development

Image Credit: AMSBIO

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

Product News

This test quantifies BCR-ABL the gene fusion that causes CML, in the blood. Though no criteria been established to determine when therapy can be stopped, the detection of low BCR-ABL levels may help physicians provide their patients with the best possible treatment.

READ MORE

CRISPR/Cas9 Knockout Cell Lines and Lysates

Product News

AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.

READ MORE

Theraly Fibrosis Inc. Licenses Scarab Genomics’ Bacterial Production Technologies for its Pharmaceutical Program

Product News

Licensing agreement provides a unique opportunity to develop curative therapies for multiple life-threatening fibrotic conditions.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE